Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

DiaMedica Therapeutics Inc DMAC

DiaMedica Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on improving the lives of people suffering from serious diseases with a focus on acute ischemic stroke. Its lead candidate DM199 (rinvecalinase alfa) is the first pharmaceutically active recombinant (synthetic) form of the human tissue kallikrein-1 (KLK1) protein to be clinically studied in patients. KLK1 is an established therapeutic modality in Asia, with human urinary KLK1, for the treatment of acute ischemic stroke and cardio renal disease, including hypertension. It has also produced a potential novel treatment for severe inflammatory diseases, DM300, which is in the early preclinical stage of development. KLK1 is a serine protease, or protein, produced primarily in the kidneys, pancreas and salivary glands. KLK1 plays a critical role in the regulation of local blood flow and vasodilation in the body, as well as an important role in reducing inflammation and oxidative stress.


NDAQ:DMAC - Post by User

Bullboard Posts
Comment by Winnipeg40on Apr 15, 2015 9:38pm
139 Views
Post# 23634597

RE:RE:RE:Now what?

RE:RE:RE:Now what?<"i've been holding now for years now at a much, much higher average price :( but haven't sold any shares. these guys have been adding quality people to their board and executive team - guys with proven track records on taking a company from trials to partnerships. great pipeline of development. i no longer swet the back and forth stock moves from 1.50 - .50. looking forward to that big wave that will lift us 4-5x once big pharma comes knocking. " remember that post....maybe they should develop a drug for schizophrenia for you lol been="" holding="" now="" for="" years="" now="" at="" a="" much,="" much="" higher="" average="" price="" :(="" but="" haven't="" sold="" any="" shares.="" these="" guys="" have="" been="" adding="" quality="" people="" to="" their="" board="" and="" executive="" team="" -="" guys="" with="" proven="" track="" records="" on="" taking="" a="" company="" from="" trials="" to="" partnerships.="" great="" pipeline="" of="" development.="" i="" no="" longer="" swet="" the="" back="" and="" forth="" stock="" moves="" from="" 1.50="" -="" .50.="" looking="" forward="" to="" that="" big="" wave="" that="" will="" lift="" us="" 4-5x="" once="" big="" pharma="" comes="" knocking.="" "="" remember="" that="" post....maybe="" they="" should="" develop="" a="" drug="" for="" schizophrenia="" for="" you="">
Bullboard Posts